Prehypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive a 500 mg capsule containing standardized garlic extract (allicin, The exact dose will be determined during the practical work),
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: "People in Their 30s and 70s (Men and Women) Who Have Recently or At Least Three Months Received a Diagnosis of Pre-hypertension"
Exclusion criteria
Exclusion criteria: People with Allergies to Garlic and its Side Effects People with Cardiovascular Problems and Diseases. Patients Who Have Previously been Diagnosed with High Blood Pressure and are Taking Antihypertensive Drugs. People with Diabetes. People who Have recently had surgery. People Who Have Recently Received Anesthetics. People with Blood Disorders Who are Taking Anticoagulants People with a History of Gallstones. People with a History of Hypoglycemia. Pregnant and Lactating Women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure (Systolic, Diastolic, Pulse pressure, Mean arterial pressure). Timepoint: "Measurement of blood pressure at the beginning of the study (before the intervention) and 4 weeks after the intervention and at the end of the study (8 weeks after the start of the study)". Method of measurement: "Mercury Barometer".;Nitric oxide metabolite level. Timepoint: Before the intervention, four weeks after the intervention, end of the intervention (eight weeks after the intervention). Method of measurement: Grace method.;Triglyceride. Timepoint: Before the intervention, four weeks after the intervention, end of the intervention (eight weeks after the intervention). Method of measurement: Autoanalyzer device.;Cholesterol. Timepoint: Before the intervention, four weeks after the intervention, end of the intervention (eight weeks after the intervention). Method of measurement: Autoanalyzer device.;Low Density Lipoprotein (LDL). Timepoint: Before the intervention, four weeks after the intervention, end of the intervention (eight weeks after the intervention). Method of measurement: Autoanalyzer device.;High Density Lipoprotein (HDL). Timepoint: Before the intervention, four weeks after the intervention, end of the intervention (eight weeks after the intervention). Method of measurement: Autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Nazari
Khoram-Abad University of Medical Sciences
Outcome results
None listed